| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/13/2001 | US6201111 Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors |
| 03/13/2001 | US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents |
| 03/13/2001 | US6201107 Cystic fibrosis gene |
| 03/13/2001 | US6201106 Cytokine signal regulators |
| 03/13/2001 | US6201104 Amino acid sequences of angiogenesis-inhibiting protein receptor; drug screening; isolation of angiogenesis related proteins |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6201086 Electrically conductive electroactive functionalized conjugated polymers, and uses thereof |
| 03/13/2001 | US6200812 Sequence alterations using homologous recombination |
| 03/13/2001 | US6200807 Antisense inhibition of SHP-2 expression |
| 03/13/2001 | US6200803 Preventing fungal contamination in cell culture by incubating cells in cell culture medium with either antisense oligonucleotide or ribozyme complementary to messenger rna of essential yeast genes |
| 03/13/2001 | US6200796 Nucleotide and amino acid sequences; recombinant production; treatment of urolithiasis and hyperoxaluria |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200782 Fusion proteins linked to nucleotide sequences; for the preferential adjustment of nucleotide sequences |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200773 Diagnostics based on tetrazolium compounds |
| 03/13/2001 | US6200772 Modified polyurethane membrane sensors and analytical methods |
| 03/13/2001 | US6200771 Determination cyclooxygenase inhibition and phosphodiesteraseinhibition; calibration |
| 03/13/2001 | US6200770 Protein kinase molecules and uses therefor |
| 03/13/2001 | US6200769 Mammalian CDP-diacylglycerol synthase |
| 03/13/2001 | US6200768 Detecting compounds efficient in the dissolution of an alzheimer's protein; incubate preferential protein with kinase, monitor helix formation, incubate with modulator and detect blocking action by modulator |
| 03/13/2001 | US6200767 Composition for accurate detection cells in food and beverages |
| 03/13/2001 | US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein |
| 03/13/2001 | US6200762 Photon reducing agents and compositions for fluorescence assays |
| 03/13/2001 | US6200761 Mixture of two nucleic acids |
| 03/13/2001 | US6200760 Screening for prophylaxis or treatment of cancer or inflammation; providing genetically engineered cells, detecting reduction in transcriptional or preferential reporter genes by anticarcinogenic or prophylactic agents |
| 03/13/2001 | US6200759 Interaction trap assay, reagents and uses thereof |
| 03/13/2001 | US6200758 Detecting a psychological disorders; obtain biopsies, detect nucleotide sequence variation, presence of variation indicates psychological disorders |
| 03/13/2001 | US6200757 Preferential chain elongation of a primer; mix blocking agent and primers, heat mixture causing the blocking agent to irreversibly denature from primer and permit chain extension, recover preferential products |
| 03/13/2001 | US6200756 Methods for identifying methylation patterns in a CpG-containing nucleic acid |
| 03/13/2001 | US6200754 Inhibitors of alternative alleles of genes encoding products that mediate cell response to environmental changes |
| 03/13/2001 | US6200753 Blocking hybridization; incubate mixture of nucleotide sequences, heat mixture, add blocking agents, detect hybridized matched nucleotide sequences |
| 03/13/2001 | US6200752 Method and composition for detecting the presence of a nucleic acid sequence in a sample |
| 03/13/2001 | US6200749 Ajusted nucleic acid sequence; for detection of genome adjustments and preferential genetic disorders |
| 03/13/2001 | US6200748 Tagged extendable primers and extension products |
| 03/13/2001 | US6200747 Method and kits for detection of fragile X specific, GC-rich DNA sequences |
| 03/13/2001 | US6200746 Detection of enzyme inhibitor; evaluate kinase phosphorylation in presence and absence of virus, incubate with test compound, monitor decrease in enzyme activity |
| 03/13/2001 | US6200567 An antibody that binds to the common beta c chain of the receptor for gm-csf, il-3 and il-5 |
| 03/13/2001 | US6200564 Pharmaceutical compositions containing chondroitinase and uses therefor |
| 03/13/2001 | CA2125673C Dna structure-specific recognition protein and uses therefor |
| 03/13/2001 | CA2024234C Method and apparatus for reviving an electrode of a biosensor |
| 03/10/2001 | CA2314695A1 A method for providing long term stability to cells for diagnostic testing |
| 03/10/2001 | CA2281990A1 Method of characterizing a population of nucleic acids by comparative hybridization |
| 03/08/2001 | WO2001016860A2 Artificial intelligence system for genetic analysis |
| 03/08/2001 | WO2001016604A1 Screening for agents modulating tgf-beta cell signaling |
| 03/08/2001 | WO2001016597A1 In vitro transcription systems and uses |
| 03/08/2001 | WO2001016378A2 Chromosome-wide analysis of protein-dna interactions |
| 03/08/2001 | WO2001016377A2 Diagnostics and therapeutics for osteoporosis |
| 03/08/2001 | WO2001016375A2 High speed parallel molecular nucleic acid sequencing |
| 03/08/2001 | WO2001016374A2 Methods and reagents for in situ amplification |
| 03/08/2001 | WO2001016372A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 03/08/2001 | WO2001016371A2 Method for identifying nucleic acid base phosphoramidites by fluorescence spectroscopy |
| 03/08/2001 | WO2001016370A1 Arrays with mask layers and methods of manufacturing same |
| 03/08/2001 | WO2001016369A2 Uv excitable fluorescent energy transfer dyes |
| 03/08/2001 | WO2001016366A2 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks |
| 03/08/2001 | WO2001016364A2 Methods of diagnosing or prognosticating age-related macular degeneration |
| 03/08/2001 | WO2001016363A2 Rapid, highly specific detection method for pseudomonas aeruginosa using multi-probe detection |
| 03/08/2001 | WO2001016361A2 Method for detecting and quantifying first biopolymers that are located in a liquid |
| 03/08/2001 | WO2001016360A1 A rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 03/08/2001 | WO2001016358A2 Method of screening for triacyglycerol hydrolase inhibitors |
| 03/08/2001 | WO2001016357A2 Novel target for antiparasitic agents and inhibitors thereof |
| 03/08/2001 | WO2001016356A1 Method for identifying an individual at risk for vascular and cancer disease |
| 03/08/2001 | WO2001016355A2 In vitro test system for gamma-secretase from enriched membranes |
| 03/08/2001 | WO2001016335A2 Stromelysin-homologous novel mmp-27 matrix metalloproteinase |
| 03/08/2001 | WO2001016330A2 Prevention of affections associated with porcine circovirus-2 |
| 03/08/2001 | WO2001016326A2 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 03/08/2001 | WO2001016322A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016317A2 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | WO2001016315A1 sIGH AFFINITY CHOLINE TRANSPORTER |
| 03/08/2001 | WO2001016314A1 Iren protein, its preparation and use |
| 03/08/2001 | WO2001016310A1 Highly sensitive method of detecting gene mutation |
| 03/08/2001 | WO2001016304A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 03/08/2001 | WO2001016303A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016292A2 37 staphylococcus aureus genes and polypeptides |
| 03/08/2001 | WO2001016291A2 07cg27 gene |
| 03/08/2001 | WO2001016290A2 Dna encoding the human serine protease eos |
| 03/08/2001 | WO2001016289A2 Zymogen activation system |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016181A2 Crystal structures of domains of receptor protein tyrosine kinases and their ligands |
| 03/08/2001 | WO2001016176A2 Transgenic animal model for neurodegenerative diseases |
| 03/08/2001 | WO2001016171A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016165A2 Apoptin-associating protein |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016154A1 Method to determine predisposition to hypertension |
| 03/08/2001 | WO2001016150A2 Nucleoside analogues |
| 03/08/2001 | WO2001016149A2 2-azapurine compounds and their use |
| 03/08/2001 | WO2001015800A1 Method and device for performing operations at charged microlocations |
| 03/08/2001 | WO2001015740A1 Single-stranded oligodeoxynucleotide mutational vectors |
| 03/08/2001 | WO2001015739A1 Antisense modulation of human rho family gene expression |
| 03/08/2001 | WO2001015676A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | WO2000073501A3 Nucleic acid molecules with specific identification of native prpsc, their production and the use thereof |
| 03/08/2001 | WO2000071754A8 Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors |
| 03/08/2001 | WO2000066735A3 Human ion channel proteins |
| 03/08/2001 | WO2000065349A3 Method for determining plasminogen activator inhibitor |